79289202 - XL-PROTEIN

Information

• Trademark
• 79289202

• Source

• Serial Number

  79289202

• Registration Number

  6617137

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  May 18, 2020
  4 years ago

• Registration Date

  January 18, 2022
  3 years ago

• Transaction Date

  July 18, 2022
  2 years ago

• Status Date

  January 18, 2022
  3 years ago

• Published for Opposition Date

  November 02, 2021
  3 years ago

• Location Date

  January 18, 2022
  3 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  VAGHANI, MAYUR C

• Attorney Docket Number

  XLPR-2002US0

  Attorney Name

  Anthony G. Craig

  Law Office Assigned Location Code

  N60

• Owners

  • XL-PROTEIN GMBH

Case File Statements

• GS0051: Pharmaceutical, medical and veterinary preparations for the treatment of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases or bone diseases; Pharmaceutical preparations for the treatment of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, or bone diseases and diagnostic reagents for use in medicine and dentistry; Test kit reagents for use in medicine and dentistry; Chemical, biochemical and biotechnological preparations for medical and diagnostic use, namely reagents for medical purposes and solvents for sample preparation, modification and manipulation of cells as well as for use in methods for labeling, separation, isolation, purification, multiplication and analysis of biopolymers, especially nucleic acids, proteins, macromolecules and biologically active substances for medical diagnostic use; Drugs for preventive, curative and palliative purposes, namely for the treatment of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, or bone diseases; Diagnostic medical biomarkers, especially for preventive, diagnostic, prognostic or predictive use; Medical preparations, namely, kits for use in medical laboratories, especially for preventive, diagnostic, prognostic or predictive use composed of proteinaceous reagents for medical purposes; Biomolecules for medical use, namely, for binding of active agents in the field of treatment of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, or bone diseases; Medical preparations for use in medical diagnostic for the treatment of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, or bone diseases; Chemical and biological preparations for medical and diagnostic purposes for the treatment of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, or bone diseases
• GS0011: Chemical and biochemical preparations for use in biochemical research laboratories, in chemical research laboratories, in biotechnological research laboratories or in pharmaceutical research laboratories, other than for medical and veterinary use, as well as for industrial and scientific use
• GS0421: Scientific and technological services and research, namely, scientific research, analysis, and testing, and research all in the field of chemistry, genetics, biology, biotechnology and biochemistry; Medical or scientific laboratory services, namely, testing services in the field of DNA, RNA as well as protein expression, detection and analysis and design relating thereto, especially in the field of chemistry, genetics, biology, biotechnology and biochemistry; Services of a chemical and biochemical scientific or medical laboratory; Technological services, namely, technical processing in the nature of product development and technical scientific analysis of biomaterials and medically relevant data especially for scientific and industrial research

Case File Event Statements

• 7/18/2022 - 2 years ago

  33 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 6/27/2022 - 2 years ago

  32 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 6/27/2022 - 2 years ago

  31 - FINAL DISPOSITION PROCESSED Type: FIMP

• 4/18/2022 - 2 years ago

  30 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 1/18/2022 - 3 years ago

  29 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 1/1/2022 - 3 years ago

  28 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 12/15/2021 - 3 years ago

  27 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 12/15/2021 - 3 years ago

  26 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 11/8/2021 - 3 years ago

  25 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 11/2/2021 - 3 years ago

  24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/2/2021 - 3 years ago

  23 - PUBLISHED FOR OPPOSITION Type: PUBO

• 10/13/2021 - 3 years ago

  22 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 10/13/2021 - 3 years ago

  21 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 10/13/2021 - 3 years ago

  20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 9/29/2021 - 3 years ago

  19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/28/2021 - 3 years ago

  18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/28/2021 - 3 years ago

  17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/28/2021 - 3 years ago

  16 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 3/30/2021 - 3 years ago

  15 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 3/30/2021 - 3 years ago

  14 - FINAL REFUSAL E-MAILED Type: GNFR

• 3/30/2021 - 3 years ago

  13 - FINAL REFUSAL WRITTEN Type: CNFR

• 3/10/2021 - 3 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/9/2021 - 3 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/9/2021 - 3 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 10/4/2020 - 4 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 9/14/2020 - 4 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 9/14/2020 - 4 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 8/18/2020 - 4 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 8/17/2020 - 4 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/14/2020 - 4 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 7/14/2020 - 4 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 7/10/2020 - 4 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 7/9/2020 - 4 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR